Stock SVS SVAS BIOSANA S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Svas Biosana S.p.A.

Equities

SVS

IT0005469264

Real-time Borsa Italiana
Other stock markets
 08:15:26 2024-05-23 am EDT 		5-day change 1st Jan Change
8 EUR -0.62% Intraday chart for Svas Biosana S.p.A. -0.62% 0.00%
May. 10 Mib rises above 34,500; Iveco leads rises AN
May. 09 Svas Biosana increases revenues by single digits in first quarter AN

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.57 for the 2024 fiscal year.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SVAS BIOSANA S.P.A. Stock Svas Biosana S.p.A.
0.00% 47.09M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.77% 182B
C+
MEDTRONIC PLC Stock Medtronic plc
+4.10% 114B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.85% 67.76B
A
DEXCOM, INC. Stock DexCom, Inc.
+5.19% 51.91B
B-
CENCORA, INC. Stock Cencora, Inc.
+5.54% 43.23B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.07% 41.07B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+23.81% 32.07B
B
TERUMO CORPORATION Stock Terumo Corporation
+15.86% 25B
A-
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.95% 24.55B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SVS Stock
  4. Ratings Svas Biosana S.p.A.